The role for osmotic agents in children with acute encephalopathies: A systematic review

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Gwer, Samson ^a,b   Gatakaa, Hellen ^b,c   Mwai, Leah ^a,b   Idro, Richard ^a,d   Newton, Charles R ^a,e,f  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Joanna Briggs Evidence Synthesis Group   (Kenya)

^c INTERNATIONAL CENTRE OF INSECT PHYSIOLOGY AND ECOLOGY ICIPE   (Kenya)

^d MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLYCEROL; MANNITOL; OSMOTIC AGENT; PLACEBO; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; SORBITOL; UREA; ISOTONIC SOLUTION; OSMOTIC DIURETIC AGENT; RINGER'S LACTATE;

ACUTE BRAIN DISEASE; ARTICLE; BACTERIAL MENINGITIS; BRAIN MALARIA; CHILD; CLINICAL TRIAL; COMA; CONTINUOUS INFUSION; DRUG EFFICACY; HUMAN; INTRACRANIAL PRESSURE; MORTALITY; NEUROLOGIC DISEASE; RESUSCITATION; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; ACUTE DISEASE; BRAIN DISEASE; DRUG EFFECT; INTRACRANIAL HYPERTENSION; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN DISEASES; CHILD; DIURETICS, OSMOTIC; GLYCEROL; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; ISOTONIC SOLUTIONS; MANNITOL; PROGNOSIS; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME;

EID: 77950884307     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-23     Document Type: Article

References (36)

1. Newton CR, Crawley J, Sowumni A, Waruiru C, Mwangi I, English M, Murphy S, Winstanley PA, Marsh K, Kirkham FJ. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997, 76(3):219-226. 10.1136/adc.76.3.219, 1717090, 9135262.
2. Goitein KJ, Amit Y, Mussaffi H. Intracranial pressure in central nervous system infections and cerebral ischaemia of infancy. Arch Dis Child 1983, 58(3):184-186. 10.1136/adc.58.3.184, 1627839, 6838249.
3. Solomon T, Dung NM, Kneen R, Thao le TT, Gainsborough M, Nisalak A, Day NP, Kirkham FJ, Vaughn DW, Smith S, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002, 125(Pt 5):1084-1093. 10.1093/brain/awf116, 11960897.
4. Papo I, Caruselli G, Luongo A. Intracranial pressure in children and adolescents with severe head injuries. J Neurosurg Sci 1982, 26(3):193-198.
5. Lindvall P, Ahlm C, Ericsson M, Gothefors L, Naredi S, Koskinen LO. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 2004, 38(3):384-390. 10.1086/380970, 14727209.
6. Nara I, Shiogai T, Hara M, Saito I. Comparative effects of hypothermia, barbiturate, and osmotherapy for cerebral oxygen metabolism, intracranial pressure, and cerebral perfusion pressure in patients with severe head injury. Acta Neurochir Suppl 1998, 71:22-26.
7. Oertel M, Kelly DF, Lee JH, McArthur DL, Glenn TC, Vespa P, Boscardin WJ, Hovda DA, Martin NA. Efficacy of hyperventilation, blood pressure elevation, and metabolic suppression therapy in controlling intracranial pressure after head injury. J Neurosurg 2002, 97(5):1045-1053. 10.3171/jns.2002.97.5.1045, 12450025.
8. Rutigliano D, Egnor MR, Priebe CJ, McCormack JE, Strong N, Scriven RJ, Lee TK. Decompressive craniectomy in pediatric patients with traumatic brain injury with intractable elevated intracranial pressure. J Pediatr Surg 2006, 41(1):83-87. discussion 83-87, 10.1016/j.jpedsurg.2005.10.010, 16410113.
9. Zornow MH, Oh YS, Scheller MS. A comparison of the cerebral and haemodynamic effects of mannitol and hypertonic saline in an animal model of brain injury. Acta Neurochir Suppl (Wien) 1990, 51:324-325.
10. Regoli F, Winston GW. Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol 1999, 156(2):96-105. 10.1006/taap.1999.8637, 10198274.
11. Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998, 79(1):1-53. 10.1016/S0163-7258(98)00008-4, 9719344.
12. Soriano SG, McManus ML, Sullivan LJ, Rockoff MA, Black PM, Burrows FA. Cerebral blood flow velocity after mannitol infusion in children. Can J Anaesth 1996, 43(5 Pt 1):461-466. 10.1007/BF03018107, 8723852.
13. Shackford SR, Zhuang J, Schmoker J. Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg 1992, 76(1):91-98. 10.3171/jns.1992.76.1.0091, 1727174.
14. Silva JC, de Melo Tavares de Lima F, Valenca MM, de Azevedo Filho HR. Hypertonic saline more efficacious than mannitol in lethal intracranial hypertension model. Neurol Res 2009,
15. Segal S, Gallagher AC, Shefler AG, Crawford S, Richards P. Survey of the use of intracranial pressure monitoring in children in the United Kingdom. Intensive Care Med 2001, 27(1):236-239. 10.1007/s001340000717, 11280641.
16. Jacinda Wilson SH, Sandy S, Jenny A. Appropriateness of using a symbol to identify dementia and/or delirium: a systematic review. Dementia Collaborative Research Centre 2007, 1-61.
17. Cruz J, Nakayama P, Imamura JH, Rosenfeld KG, de Souza HS, Giorgetti GV. Cerebral extraction of oxygen and intracranial hypertension in severe, acute, pediatric brain trauma: preliminary novel management strategies. Neurosurgery 2002, 50(4):774-779. discussion 779-780, 10.1097/00006123-200204000-00017, 11904028.
18. Kingston ME. Experience with urea in invert sugar for the treatment of cerebral malaria. J Trop Med Hyg 1971, 74(11):249-252.
19. Prabhakaran P, Reddy AT, Oakes WJ, King WD, Winkler MK, Givens TG. A pilot trial comparing cerebral perfusion pressure-targeted therapy to intracranial pressure-targeted therapy in children with severe traumatic brain injury. J Neurosurg 2004, 100(5 Suppl Pediatrics):454-459.
20. Mickell JJ, Reigel DH, Cook DR, Binda RE, Safar P. Intracranial pressure: monitoring and normalization therapy in children. Pediatrics 1977, 59(4):606-613.
21. James HE. Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien) 1980, 51(3-4):161-172. 10.1007/BF01406742, 6768226.
22. James HE, Langfitt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir (Wien) 1977, 36(3-4):189-200. 10.1007/BF01405391, 848367.
23. Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, Martin C. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003, 31(6):1683-1687. 10.1097/01.CCM.0000063268.91710.DF, 12794404.
24. Marshall LF, RW SM, Rauscher LA, Shapiro HM. Mannitol dose requirements in brain-injured patients. J Neurosurg 1978, 48(2):169-172. 10.3171/jns.1978.48.2.0169, 624964.
25. MacDonald JT, Uden DL. Intravenous glycerol and mannitol therapy in children with intracranial hypertension. Neurology 1982, 32(4):437-440.
26. Fisher B, Thomas D, Peterson B. Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol 1992, 4(1):4-10. 10.1097/00008506-199201000-00002, 15815431.
27. Namutangula B, Ndeezi G, Byarugaba JS, Tumwine JK. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malar J 2007, 6:138. 10.1186/1475-2875-6-138, 2147028, 17958887.
28. Peltola H, Roine I, Fernandez J, Zavala I, Ayala SG, Mata AG, Arbo A, Bologna R, Mino G, Goyo J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007, 45(10):1277-1286. 10.1086/522534, 17968821.
29. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med 1998, 26(7):1265-1270. 10.1097/00003246-199807000-00032, 9671379.
30. Khanna S, Davis D, Peterson B, Fisher B, Tung H, O'Quigley J, Deutsch R. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000, 28(4):1144-1151. 10.1097/00003246-200004000-00038, 10809296.
31. Wald SL, McLaurin RL. Oral glycerol for the treatment of traumatic intracranial hypertension. J Neurosurg 1982, 56(3):323-331. 10.3171/jns.1982.56.3.0323, 7057229.
32. Yildizdas D, Altunbasak S, Celik U, Herguner O. Hypertonic saline treatment in children with cerebral edema. Indian Pediatr 2006, 43(9):771-779.
33. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med 2000, 28(4):1136-1143. 10.1097/00003246-200004000-00037, 10809295.
34. Berger S, Schwarz M, Huth R. Hypertonic saline solution and decompressive craniectomy for treatment of intracranial hypertension in pediatric severe traumatic brain injury. J Trauma 2002, 53(3):558-563. 10.1097/00005373-200209000-00027, 12352497.
35. Czosnyka M, Hutchinson PJ, Balestreri M, Hiler M, Smielewski P, Pickard JD. Monitoring and interpretation of intracranial pressure after head injury. Acta Neurochir Suppl 2006, 96:114-118. full_text, 16671437.
36. Procaccio F, Menasce G, Sacchi L, Boselli L. Effects of thiopentone and mannitol on cerebral perfusion pressure and E.E.G. in head injured patients with intracranial hypertension. Agressologie 1991, 32(8-9 Spec No):381-385.